ATEC Advances Lateral Surgery With Launch of Expandable Technology
16 Octobre 2023 - 10:05PM
Business Wire
Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative
solutions dedicated to revolutionizing the approach to spine
surgery, announced today that the Company’s commitment to advancing
lateral surgery will be prominent at the 2023 NASS Annual Meeting.
The Company will introduce the Calibrate LTXTM lateral expandable
implant system, technology designed to better achieve alignment
goals with precise lordosis control and disc height
restoration.
“ATEC is uniquely dedicated to improving lateral surgery,” said
Pat Miles, Chairman and Chief Executive Officer. “The release of
Calibrate LTX elevates our lateral procedural thesis by better
enabling surgeons to achieve the most elusive goal of surgery:
alignment. When it comes to alignment, EOS is the best imaging tool
to determine it, PTPTM is the best lateral procedure to achieve it
and Calibrate LTX is the expandable implant system that best drives
it. At NASS, we will demonstrate how to apply PTP in increasingly
complex procedures and how to employ LTPTM to address L3 through
S1, the most commonly treated levels in spine. Our path to becoming
the standard bearer in lateral surgery will be apparent.”
Anthony Kwon, M.D., Orthopedic Spine Surgeon at OrthoCarolina
and Atrium Medical Center in Charlotte, NC, added, "The Calibrate
LTX expandable lateral system seamlessly integrates with ATEC's
entire lateral platform. The simplicity and ease of insertion of
the implant is unique compared to the over-engineering that plagues
other expandable systems. Enhanced visibility, powerful expansion
and ease of back-filling make LTX the ideal expandable interbody
solution."
Innovation Update for Investors
Calibrate LTX will be a feature of a technology-focused meeting
for investors on October 18, 2023, from 7:30am to 9:00am PT at the
JW Marriott Los Angeles. RSVP here if you plan to join the event in
person. A webcast will be also available for those unable to
attend. To access the webcast, please visit the Investor Relations
Section of ATEC’s Corporate Website.
Booth Presentations
ATEC is partnering with renowned spine surgeons to demonstrate
how ATEC innovation can improve clinical precision and
predictability. Visit ATEC booth #1801 to view the following
presentations:
Presentation
Date
Time (PT)
Presenter
PTPTM: The Evolution of the Lateral
Approach
10/18
9:10am
Luiz Pimenta, MD, PhD
William Taylor, MD
Informing Better Spine Surgery with
Precision Technology
10/18
12:00pm
Juan Uribe, MD
Kevin Foley, MD
Streamlined Single Position Anterior
Column Approaches
10/18
3:00pm
Hardeep Singh, MD
EOS: Standardizing Care with End-To-End
Solutions
10/19
9:35am
Vedat Deviren, MD
Achieving Sagittal Alignment with PTPTM
and CalibrateTM LTX
10/19
12:00pm
Vedat Deviren, MD
Srikanth N. Divi, MD
Reducing Mechanical Complications in Adult
Spinal Deformity: Invictus® Fenestrated and S.I. Core
10/19
3:00pm
Jay Turner, MD
About ATEC
ATEC, through its wholly owned subsidiaries, Alphatec Spine,
Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical
device company dedicated to revolutionizing the approach to spine
surgery through clinical distinction. ATEC’s Organic Innovation
MachineTM is focused on developing new approaches that integrate
seamlessly with the Company’s expanding AlphaInformatiX Platform to
better inform surgery and more safely and reproducibly achieve the
goals of spine surgery. ATEC’s vision is to be the Standard Bearer
in Spine. For more information, visit us at www.atecspine.com.
Forward-Looking Statements
This press release contains "forward-looking statements" within
the meaning of the Private Securities Litigation Reform Act of 1995
that involve risks and uncertainty. Such statements are based on
management's current expectations and are subject to a number of
risks and uncertainties that could cause actual results to differ
materially from those described therein. Forward-looking statements
include references to the Company’s expectations with respect to
future revenue and growth and planned commercial launches,
introductions, integration, regulatory submissions or clearances.
The important factors that could cause actual operating results to
differ significantly from those expressed or implied by such
forward-looking statements include, but are not limited to: failure
to achieve acceptance of the Company’s products by the surgeon
community and the uncertainty of success in developing new products
or products currently in the pipeline. The words “believe,” “will,”
“should,” “expect,” “intend,” “estimate,” “look forward” and
“anticipate,” and variations of such words and similar expressions
identify forward-looking statements, but their absence does not
mean that a statement is not a forward-looking statement. A further
list and description of these and other factors, risks and
uncertainties can be found in the Company's most recent annual
report, and any subsequent quarterly and current reports, filed
with the Securities and Exchange Commission. ATEC disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise, unless required by law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231016459805/en/
Investor/Media Contact: Tina Jacobsen, CFA Investor
Relations (760) 494-6790 investorrelations@atecspine.com
Company Contact: J. Todd Koning Chief Financial Officer
Alphatec Holdings, Inc. investorrelations@atecspine.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024